Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Supplement
-
Reference no. 9-318-120
Published by: Harvard Business Publishing
Originally published in: 2018
Version: 7 March 2018
Revision date: 15-Oct-2019
Length: 6 pages
Data source: Published sources

Abstract

Supplement to the A case. In the battle for control over China Vanke, the Chinese securities regulator steps in to censure Vanke and Baoneng for acting against the interests of the market and minority shareholders. The Chinese insurance regulator also finds Baoneng to be in violation of insurance regulations, and subjects its insurance arm to severe restrictions on further sales of its products. A rival private property developer, China Evergrande, also joins the fray, buying enough shares to become Vanke's third largest shareholder. The case finally relays how the battle for control winds down and the eventual resolution.
Location:
Industry:
Size:
> 1 billion; Large
Other setting(s):
2015-2017

About

Abstract

Supplement to the A case. In the battle for control over China Vanke, the Chinese securities regulator steps in to censure Vanke and Baoneng for acting against the interests of the market and minority shareholders. The Chinese insurance regulator also finds Baoneng to be in violation of insurance regulations, and subjects its insurance arm to severe restrictions on further sales of its products. A rival private property developer, China Evergrande, also joins the fray, buying enough shares to become Vanke's third largest shareholder. The case finally relays how the battle for control winds down and the eventual resolution.

Settings

Location:
Industry:
Size:
> 1 billion; Large
Other setting(s):
2015-2017

Related